Bio-IT World 2020 features a robust lineup of AI presentations, including two tracks focused on Drug Discovery and Emerging Technologies. Click on each track to view its full agenda. Can't decide on a single track? Bio-IT World encourages track hopping
to help attendees maximize their onsite experience.
CONFERENCE PROGRAMS
The use of artificial intelligence in biopharma has redefined how scientists develop new drugs, tackle disease, and more. The AI for Drug Discovery track will discuss problems that biopharma organizations are experiencing in harnessing the power
of AI and machine learning technologies to maximize and accelerate drug discovery efforts from early stage to adoption to practical application. Speakers will explore the role of AI in developing new drugs, tackling diseases previously deemed
too difficult to take on, the R&D process, chemical synthesis optimization, drug repositioning, making sense of clinical data, predicting clinical trial outcomes, finding correct patients for clinical trials, analyzing real-world evidence,
making sense of complex medical data, and avoiding "brittle" results based on too little/biased data.
View Program
AI technologies are essential to the advancement of precision medicine. There is no shortage of examples of how they can be leveraged from R&D to translational research, clinical trials, and real-world data. However, the current round of solutions
can be expensive and complex to deploy and manage. The Emerging AI Technologies track will explore currently deployed use cases of AI technology, what problems have been addressed successfully, where there are some challenges, and what future
technology developments to keep an eye on, such as machine vision, emotion gestures/affective computing, NLP, NLG, knowledge graphs, deep learning, reinforcement learning, quantum computing, synthetic data, and more. Hear from pharma industry
use cases, as well as technology users and emerging technology solution providers.
View Program
REGISTER
RECOMMENDED WORKSHOPS*
Workshop 2 – A Crash Course in AI: 0-60 in Three
Have you ever been curious to apply machine learning to large amounts of data but were not sure of the concepts to use? Have you ever wondered how to get started on AI? Well, you have come to the right place! This workshop will help you learn AI
like never before (our instructors guarantee it!). The workshop is a crash course on AI where you will learn the fundamentals and applications of AI/ML in Pharma. Come join us, learn, and network! - Detailed Agenda
Workshop 5 - AI-Celerating R&D: Foundational Approaches to How Emerging Technologies Can Generate Value
The potential of emerging technologies like Artificial Intelligence, Robotic Process Automation, Quantum Computing, Blockchain/Distributed Ledger Technology, Internet of Things and more to fundamentally change business models and the way business
is conducted cannot be understated. In an overtly buzzword crazy session (buzzword bingo cards will be provided), we’ll work through real practical ways to define, derive, and deliver value from emergent technologies. - Detailed Agenda
*Separate registration required
REGISTER
2020 AI Presenters
- Navid Alipour, PhD, Co-Founder & Managing Partner, Analytics Ventures
- Brandon Allgood, PhD, Senior Vice President, Data Science & AI, Integral
- Mohammed AlQuraishi, PhD, Assistant Professor, Systems Biology, Columbia University
- Peter Andersen, Advanced Advisory Consultant, Life Sciences Advisory, NNIT
- Ardy Arianpour, CEO & Co-Founder, Seqster PDM, Inc.
- Dorothee B. Bartels, PhD, Lead, Clinical & Real World Data Strategy, X Alphabet
- Lawrence Callahan, PhD, Chemist, Global Substance Registration System/Office of Health Informatics, Office of Chief Scientist, FDA
- Tanya Cashorali, CEO, TCB Analytics LLC
- Corey Centen, CEO & Co-Founder, Bodyport
- Sean J. Cheng, PhD, Senior Investment Manager, Philips Ventures
- Amit Chourasia, Visualization Group Leader, University of California San Diego
- Michael C. Conway, Technical Architect, Office of Data Science, NIH NIEHS
- Mark Davies, Senior Vice President, Informatics and Data, Biomedical Informatics, BenevolentAI
- Tom Defay, Senior Director, R&D Strategy and Alliances, SPMD, Program Management and Data Sciences, Alexion
- Helena F Deus, PhD, Biomedical Semantics Solutions Lead, ZS Associates
- Jiarui Ding, PostDoc Associate, Broad Institute
- Jessica J. Federer, Venture Affiliate Partner, Boston Millennia Partners
- James K. Ferri, PhD, Professor, Associate Department Chair and Undergraduate Program Director, Department of Chemical and Life Science Engineering, Virginia Commonwealth University
- Richard Goodwin, PhD, Director & Head, Imaging and Artificial Intelligence, Imaging and Data Analytics, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
- Philipp Harbach, Head of In Silico Research, EMD Digital
- Richard Head, MS, Professor, Genetics and Pathology & Immunology; Director, Genomics, McDonnell Genome Institute Genetics; Genome Technology Access Center at the McDonnell Genome Institute (GTAC@MGI), Washington University School of Medicine
- Peter V. Henstock, PhD, AI & Machine Learning Tech Lead, Software Engineering & Statistics & Visualization, Pfizer Inc.
- Spencer Hey, PhD, Faculty and Co-Director of Research Ethics, Harvard Center for Bioethics, Harvard Medical School
- Alexander Ivliev, PhD, Director, Bioinformatics, Clarivate AnalyticsMichael Riener, President, RCH Solutions
- Charles Jaffe, MD, PhD, Chief Executive Officer, Health Level 7
- Adam M Jenkins, PhD, Assoc Dir Global Data Science, Commercial Excellence & Operations, Biogen
- Ewa Jermakowicz, IT Business Partner, Scientific Decision Support Network, Roche
- Danny Katzel, Senior Software Engineer, National Center for Advancing Translational Science, NIH
- Michael Langer, Head of Search and Evaluation, Pear Therapeutics
- Debbie W. Lin, PhD, Executive Director, Boehringer Ingelheim Venture Fund
- Nick Lynch, PhD, Founder & CTO, Curlew Research
- Brian Martin, Head of AI, R&D Information Research, Senior Principal Data Scientist, AbbVie
- Luis A. Mendez, Senior Scientist, Drug Discovery, Bristol Myers Squibb Co.
- Celia Merzbacher, PhD, Associate Director, Quantum Economic Development Consortium, SRI International
- Annastasiah M. Mhaka, PhD, Co-Founder & Convenor, Mawambo Lifesciences
- David Milward, Dr., Senior Director, NLP Technology, Linguamatics, an IQVIA Company
- Oleg Moiseyenko, Sr Cloud Architect, Scientific Computing Systems, Bristol Myers Squibb
- Omesan Nair, PhD, Design Analyst, Operational Design Center (ODC), Global Clinical Operations, EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany
- Eric Neumann, PhD, CEO & Founder, AIDAKA LLC
- Carolina Nobre, PhD, PostDoc Fellow, Harvard University
- Philip R.O. Payne, PhD, FACMI, FAMIA, Becker Professor and Chief Data Scientist, Washington University in St. Louis, School of Medicine
- Srikanth Ramakrishnan, Business Technology Leader, IT, Janssen R&D
- Meghan Raman, Director, R&D Data Lake & Analytics, Bristol Myers Squibb Co.
- Brigitte E. Raumann, Product Manager, Globus, University of Chicago
- Jane Reed, Director, Life Science, Linguamatics, an IQVIA Company
- Kimberly Robasky, PhD, Head, Translational Science, Renaissance Computing Institute (RENCI)
- Philip Ross, PhD, Director, Clinical Data Utilization, Knowledge Science Research, Bristol-Myers Squibb
- Esteban Rubens, Healthcare AI Principal, NetApp
- Terrell Russell, PhD, Chief Technologist, The iRODS Consortium at Renaissance Computing Institute (RENCI)
- Alok Saldanha, PhD, Technical Associate Director, NIBR Informatics, Novartis Institutes for Biomedical Research
- Heather Shapiro, PhD, Head, Data Science, Pear Therapeutics
- Raveen Sharma, Managing Director, Life Sciences and Healthcare, Deloitte Consulting LLP
- Vishakha Sharma, PhD, Principal Data Scientist, Roche Molecular Systems Inc.
- Shantanu Singh, PhD, Senior Group Leader, Imaging Platform, Broad Institute
- Ola Spjuth, Professor, Department of Pharmaceutical Biosciences, Uppsala University
- Kees Van Bochove, Founder, The Hyve
- Vas Vasiliadis, Chief Customer Officer, Globus, University of Chicago
- Matt Wallace, Chief Technology Officer, Faction
- Grace Wenjia You, PhD, Director & Head, Global Portfolio Management, Valuation & Analytics, EMD Serono
- John Wise, Consultant, Pistoia Alliance Inc
- Vaughan Wittorff, PhD, Co-Founder, PetaGene
- Brian Woznik, Solutions Architect, Engineering, Igneous
- Lauren Young, Senior Scientist, Computational Biology, Beam Therapeutics
- Baohong Zhang, PhD, Head, Genome Informatics, Biogen
- Alex Zhavoronkov, PhD, Founder & CEO, Insilico Medicine